We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug That Combats Memory Loss in Alzheimer's Enters Phase II Trials

News   Sep 10, 2019 | Original story from the University at Buffalo

 
Drug That Combats Memory Loss in Alzheimer's Enters Phase II Trials
 
 
 

RELATED ARTICLES

Novel Neurological Syndrome Common in Countries Where Consanguineous Marriage is Prevalent

News

Scientists may have discovered a new neurological syndrome that seems to be most common in countries with high prevalence of marriage between genetically-related individuals.

READ MORE

Epigenetic Drug Screens Could Unlock New Treatments for Cancer, Heart Disease and Mental Illness

News

Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a machine-learning algorithm that gleans information from microscope images--allowing for high-throughput epigenetic drug screens that could unlock new treatments for cancer, heart disease, mental illness and more.

READ MORE

Blood Pressure Drugs Work Best at Bedtime

News

People with high blood pressure who take their anti-hypertensive drugs in one go at bedtime have better controlled blood pressure and a lower risk of death or illness caused by heart or blood vessel problems, compared to people who take their medication in the morning, says new research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE